The clinical utility of hsTnT and NT-proBNP in heart failure and CAD assessment has been well-validated, with hsTNT and NT-proBNP more frequently linked to the development of heart failure in CKD patients than CAD [5,33]. The gene discussed is NPPB; the disease is heart failure.